Meeting Review: FemtoKeratoplasty Forum 2013

Article

The authors present highlights of the fourth FemtoKeratoplasty meeting held earlier this year.

Versatile tool

Penetrating keratoplasty

For penetrating keratoplasty (PKP), the zig-zag profile with angled edges inspired by self-sealing cataract incisions provides more surface area for wound healing, greater mechanical stability of wound incisions and better incision alignment, according to Dr Farid,2 who recommended a posterior bridge of uncut tissue of 70 μm. This dissection pattern for PKP using the femtosecond laser technology has been shown to be clearly superior to conventional trephination in terms of visual acuity and astigmatism control, always using the same size and profile for host and donor.3 One additional advantage of the zig-zag profile, as pointed out by Prof. Alió, is that coaptation of the donor-host interface in PKP is better compared to top-hat or mushroom patterns. This was confirmed in a study evaluating donor-host interface elevation using optical coherence tomography (OCT) conducted by his team.4 In contrast, the mushroom pattern does not automatically align the anterior surface, but preserves more host endothelium.5

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.